‘Microbiome’ aims to support companies worldwide in the development, process validation, and commercial production of probiotics, postbiotics, Next-Generation bacteria and live biotherapeutics (LBPs).
According to Marco Caspani, Executive Director of the Microbiome Division of Sacco System, the company has been working with Biotherapeutics for many years: CSL Centro Sperimentale del Latte has been among the first producers of probiotics to boast a facility qualified for the manufacturing of microbial pharmaceutical ingredients. With the launch of this new Microbial Therapeutic business-line Sacco System is directing his efforts and strong focus to the field of Biotherapeutics.
